Search En menu ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

    Signature(s)

    Amount
    € 150,000,000
    Countries
    Sector(s)
    Belgium : € 67,500,000
    United Kingdom : € 82,500,000
    Services : € 150,000,000
    Signature date(s)
    15/12/2015 : € 67,500,000
    15/12/2015 : € 82,500,000

    Summary sheet

    Release date
    26 June 2015
    Status
    Reference
    Signed | 15/12/2015
    20150218
    Project name
    Promoter - financial intermediary
    UCB NOVEL DRUG CANDIDATES
    UCB SA
    Proposed EIB finance (Approximate amount)
    Total cost (Approximate amount)
    EUR 150 million
    EUR 426 million
    Location
    Sector(s)
    • Services - Professional, scientific and technical activities
    Description
    Objectives

    Financing of UCB New Medicines activities in the fields of neuroscience (Braine-l'Alleud, Belgium) and immunology (Slough, UK) over the period 2015-2017

    The project concerns the discovery research, non-clinical developments and early clinical developments, i.e. finding and confirming candidates and progressing them through proof of concept stage in the areas of neurology and immunology.

    Environmental aspects
    Procurement

    The project mainly concerns investments in research and development (R&D) that are expected to be carried out in existing facilities already authorised for the same purpose and would therefore not require an environmental impact assessment (EIA) under Directive 2011/92/EU. Full environmental details will be verified during the appraisal.

    The promoter has been assessed by the EIB as being a private company not operating in the utilities sector and not having the status of a contracting entity, thus not subject to EU rules on public procurement. However, if, after the project appraisal, the EIB were to conclude that the promoter is after all subject to EU public procurement legislation (i.e. Directive 2004/17/EC), then the Bank would require the promoter to ensure that contracts for the implementation of the project have been/will be tendered in accordance with the relevant applicable EU procurement legislation (Directive 2004/17/EC and Directive 92/13/EEC), with publication of tender notices in the EU Official Journal, as and where required.

    Comments

    Professional, Scientific and Technical Activities

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Documents

    Environmental and Social Data Sheet (ESDS) - UCB NOVEL DRUG CANDIDATES
    Publication Date
    24 Nov 2015
    Document language
    Main Topic
    Lending
    Document Number
    63067006
    Document Focus
    Environmental Information
    Project Number
    20150218
    Sector(s)
    Publicly available
    Download now

    General enquiries and comments

    The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
    Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
    Alternatively, the EIB can be contacted through its external offices.
    Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

    Media enquiries

    Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

    Complaints mechanism

    Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

    Zero tolerance against fraud and corruption

    The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.

    Related publications